<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_Manchester_ManagementPart2"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu noprint"><UL><LI class="selected"><A href="/Team:Manchester/ManagementPart2">Page               </A></LI><LI class="new"><A href="/wiki/index.php?title=Talk:Team:Manchester/ManagementPart2&amp;action=edit&amp;redlink=1">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:Manchester/ManagementPart2&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:Manchester/ManagementPart2&amp;action=history">History               </A></LI><LI style="color:white;cursor:default">teams</LI></UL></DIV><DIV class="right-menu noprint" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:Manchester/ManagementPart2" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls" class="noprint"><FORM action="/Special:Search" id="searchform"> </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:Manchester/ManagementPart2</H1><DIV id="bodyContent"><H3 id="siteSub" class="noprint">From 2013.igem.org</H3><P><TITLE id="title"> page </TITLE></P><DIV class="container"><DIV id="block"><A href="https://2013.igem.org/Team:Manchester" id="link1">Home</A></DIV><DIV id="block1"><UL class="list"><LI><A href="https://2013.igem.org/Team:Manchester/Team" id="link2">Team</A></LI><LI><A href="https://igem.org/Team.cgi?id=1027" target="_blank">Team Profile</A></LI></UL></DIV><DIV id="block2"><UL class="list"><LI><A href="https://2013.igem.org/Team:Manchester/Project" id="link3">Project</A></LI><LI><A href="https://2013.igem.org/Team:Manchester/Overview" id="link3">Project Overview</A></LI><LI><A href="https://2013.igem.org/Team:Manchester/Notebook" id="link3">Notebook</A></LI><LI><A href="https://2013.igem.org/Team:Manchester/LabBook" id="link3">Lab Book</A></LI><LI><A href="https://2013.igem.org/Team:Manchester/Parts" id="link3">Parts</A></LI><LI><A href="https://2013.igem.org/Team:Manchester/Safety" id="link3">Safety</A></LI><LI><A href="https://2013.igem.org/Team:Manchester/Judging" id="link3">Judging</A></LI><LI><A href="https://2013.igem.org/Team:Manchester/Attributions" id="link3">Attributions</A></LI></UL></DIV><DIV id="block3"><UL class="list"><LI><A href="https://2013.igem.org/Team:Manchester/Modelling" id="link6">Modelling</A></LI><LI><A href="https://2013.igem.org/Team:Manchester/Enzyme" id="link6">Uncertainty Analysis</A></LI><LI><A href="https://2013.igem.org/Team:Manchester/FabProteinModel" id="link6">FabA Dynamics Model</A></LI><LI><A href="https://2013.igem.org/Team:Manchester/PopulationDynamics" id="link6">Population Dynamics</A></LI><LI><A href="https://2013.igem.org/Team:Manchester/Collaboration" id="link6">Modelling Collaboration</A></LI></UL></DIV><DIV id="block4"><UL class="list"><LI><A href="https://2013.igem.org/Team:Manchester/HumanPractices" id="link4">Human Practices</A></LI><LI><A href="https://2013.igem.org/Team:Manchester/Outreach" id="link4">Public Outreach</A><UL class="submenu1"><A href="https://2013.igem.org/Team:Manchester/Stars" id="link4">Science Stars</A></UL></LI><A href="https://2013.igem.org/Team:Manchester/OpenDay" id="link4">Open day</A></UL><LI><A href="https://2013.igem.org/Team:Manchester/Ethics" id="link4">Ethics</A></LI><LI><A href="https://2013.igem.org/Team:Manchester/EnvironmentPart1" id="link4">Environmental Impact</A></LI><LI><A href="https://2013.igem.org/Team:Manchester/EconomyPart1" id="link4">Economic Impact</A></LI><LI><A href="https://2013.igem.org/Team:Manchester/ManagementPart1" id="link4">Impact Management</A></LI><LI><A href="https://2013.igem.org/Team:Manchester/Conclusion" id="link4">Conclusion</A></LI><LI><A href="https://2013.igem.org/Team:Manchester/businessplan" id="link4">Business Plan</A></LI><LI><A href="https://2013.igem.org/Team:Manchester/Collaboration" id="link4">Modelling Collaboration</A></LI><LI><A href="https://2013.igem.org/Team:Manchester/KnowledgeDeficit" id="link4">Knowledge Deficit Assumption</A></LI><LI><A href="https://2013.igem.org/Team:Manchester/Conferences" id="link4">Conferences and Discussions</A></LI><LI><A href="https://2013.igem.org/Team:Manchester/SocialMedia" id="link4">Social Media</A></LI></DIV><DIV id="block5"><A href="https://2013.igem.org/Team:Manchester/Sponsorship" id="link5">Sponsorship</A></DIV></DIV><DIV class="anchor"><A href="#" class="topButton">Top</A></DIV><P><TITLE> Safety </TITLE></P><DIV class="global"><DIV class="wrapper"><DIV class="container1"><P>When doing the initial research for our synthetic alternative to palm oil components, we quickly came across lots of information regarding the current palm oil industry. It soon became apparent that the economies of some countries, for example Indonesia and Malaysia, depend almost entirely upon the current methods of palm oil production. Therefore we compiled <B>a detailed impact analysis report for synthetic palm oil</B>, which can be found by clicking on the button to the right.</P></DIV><DIV class="title">
               To Patent, Or Not To Patent, That Is The Question
            </DIV><DIV class="text1"><P>In an attempt to minimise the negative impact the commercialisation of our project would have on the economies of developing countries largely dependent on the palm oil industry, our ideas and constructs could be patented. Patenting a product derived through synthetic biology is not a new concept, in fact companies such as Givaudan have already patented microbial routes to valuable commodities such as vanillin, for example<SUP>[1]</SUP></P><P><B>Cons of patenting:</B></P><UL><LI>It could lead to the privatisation of synthetic life forms<SUP>[2]</SUP>, as well as furthering the privatisation of products and processes found within nature<SUP>[3]</SUP></LI><LI>Patenting could hinder progress in research and development, as the legislature around the patent may be very restrictive</LI><LI>Following on from above, patents can be very broad in scope. Some people feel that genomic patents should only be issued if the standard criteria of patents are clearly apparent: patents must demonstrate novelty, usefulness and non-obviousness. This would potentially alleviate some of the restriction suggested above<SUP>[2]</SUP></LI></UL><P><B>Pros of patenting:</B></P><UL><LI>Patenting leads to a protection of knowledge, which encourages researchers to publish and distribute their findings openly</LI><LI>The <A href="https://2012.igem.org/Team/CINVESTAV-IPN-UNAM_MX/home.htm" target="_blank">CINVESTAV-IPN-UNAM iGEM team 2012</A> alluded to the fact that licences could be written into a patent<SUP>[4]</SUP>, which would still protect the inventor’s work but would also make the technology accessible to others</LI></UL>
Therefore, our project could potentially be patented, and then licenced out to countries reliant on the palm oil industry either for a reduced rate, or free of charge.
<B>References</B>
[1] <A href="http://cen.acs.org/articles/90/i29/Sweet-Smell-Microbes.html" target="_blank">Bomgardner, M. M. (2012), “The Sweet Smell of Microbes”, <I>Chemical &amp; Engineering News</I>. July 16th</A>
[2] <A href="http://www.parliament.uk/documents/post/postpn298.pdf" target="_blank">UK Parliamentary Office of Science and Technology (2008). Postnote: Synthetic Biology</A>
[3] <A href="http://www.biosafety-info.net/file_dir/15148916274f6071c0e12ea.pdf" target="_blank">FotE US, CTA &amp; ETC Group. The Principles for the Oversight of Synthetic Biology</A>
[4] <A href="https://static.igem.org/mediawiki/2012/3/36/Intellectual_Property_report.pdf" target="_blank">CINVESTAV-IPN-UNAM iGEM team 2012</A>
[5] Photo ©<A href="http://www.flickr.com/photos/antphotos/with/9776476381/" target="_blank">Antony Theobald</A></DIV><DIV class="next"><A href="https://2013.igem.org/Team:Manchester/ManagementPart3"> Go to <I>Academia Vs. Government</I></A></DIV></DIV><DIV class="leftbar"><DIV class="block1"><A href="https://2013.igem.org/Team:Manchester/HumanPractices">HUMAN PRACTICES</A></DIV><DIV class="block2"><A href="https://2013.igem.org/Team:Manchester/Outreach">PUBLIC OUTREACH</A></DIV><DIV class="block3"><A href="https://2013.igem.org/Team:Manchester/Stars">SCIENCE STARS</A></DIV><DIV class="block4"><A href="https://2013.igem.org/Team:Manchester/OpenDay">OPEN DAY</A></DIV><DIV class="block5"><A href="https://2013.igem.org/Team:Manchester/Ethics">ETHICS</A></DIV><DIV class="block6"><A href="https://2013.igem.org/Team:Manchester/EnvironmentPart1">ENVIRONMENTAL IMPACT</A></DIV><DIV class="block7"><A href="https://2013.igem.org/Team:Manchester/EconomyPart1">ECONOMIC IMPACT</A></DIV><DIV class="block8"><A href="https://2013.igem.org/Team:Manchester/ManagementPart1">IMPACT MANAGEMENT</A></DIV><DIV class="block9"><A href="https://2013.igem.org/Team:Manchester/Conclusion">CONCLUSION</A></DIV><DIV class="block10"><A href="https://2013.igem.org/Team:Manchester/businessplan">BUSINESS PLAN</A></DIV><DIV class="block10"><A href="https://2013.igem.org/Team:Manchester/Collaboration">MODELLING COLLABORATION</A></DIV><DIV class="block11"><A href="https://2013.igem.org/Team:Manchester/KnowledgeDeficit">KNOWLEDGE DEFICIT ASSUMPTION</A></DIV><DIV class="block12"><A href="https://2013.igem.org/Team:Manchester/Conferences">CONFERENCES AND DISCUSSIONS</A></DIV><DIV class="block13"><A href="https://2013.igem.org/Team:Manchester/SocialMedia">SOCIAL MEDIA</A></DIV></DIV></DIV><DIV class="rightbar"><DIV class="question1"><A href="https://2013.igem.org/Team:Manchester/ManagementPart1">Is The Palm Oil Industry Irreplaceable?</A></DIV><DIV class="question2"><A href="https://2013.igem.org/Team:Manchester/ManagementPart2">To Patent, Or Not To Patent, That Is The Question</A></DIV><DIV class="question3"><A href="https://2013.igem.org/Team:Manchester/ManagementPart3">Academia Vs. Government</A></DIV><DIV class="question4"><A href="https://2013.igem.org/Team:Manchester/ManagementPart4">Could Synthetic Palm Oil and Natural Palm Oil Exist In Harmony?
</A></DIV></DIV></DIV><DIV class="printfooter">
Retrieved from &quot;<A href="http://2013.igem.org/Team:Manchester/ManagementPart2">http://2013.igem.org/Team:Manchester/ManagementPart2</A>&quot;</DIV></DIV></DIV><DIV id="footer-box" class="noprint"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:Manchester/ManagementPart2" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:Manchester/ManagementPart2" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:Manchester/ManagementPart2&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:Manchester/ManagementPart2&amp;oldid=349519" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2013.igem.org:Privacy_policy" title="2013.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2013.igem.org:General_disclaimer" title="2013.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></BODY></HTML>